ACS + 2P: 2 Flashcards

1
Q

ED: STEMI

A

-HEPARIN IV
+/-METOPROLOL IV

MONA:
1. Morphine
2. Oxygen
3. NTG SL/IV
4. Aspirin/Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Morphine: STEMI

A

1-5 mg IV Q5-30min

AVOID in lethargy, low BP, bradycardia

Morphine + Clopidogrel = DDI caution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Oxygen: STEMI

A

2-4 lpm if O2 < 90, HF, dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NTG: STEMI

A

0.4 mg Q5min x3doses

IV: 10 mcg/min if pain not controlled

Don’t use if BP < 90 or < 30 below baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aspirin: STEMI

A

325 mg asap for STEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Heparin: STEMI ED

A

If fibrinolysis:
-60 u/kg (max 4k)
-12 u/kg (max 1k)

If primary PCI/med man:
-60 u/kg (max 5k)
-12 u/kg (max 1k)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BB: STEMI

A

Metoprolol Tartrate 5 mg IV up to x3d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Reperfusion Therapy: ED for STEMI

A

– Door-2-Balloon: 90 minutes (primary PCI)
– Door-2-Needle: 30 minutes (thrombolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of patients w/ higher risk of ICH with Fibrinolysis

A

-Female
-75+
-Cerebral vascular disease
-HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tenecteplase Dosing in ED for STEMI

A
  • < 60 kg: 30 mg
  • 60-69 kg: 35 mg
  • 70-79 kg: 40 mg
  • 80-89 kg: 45 mg
  • > 90 kg: 50 mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

STEMI - Primary PCI: Cath Lab: Antithrombotic Strategies

A
  1. Continue heparin from ED as monotherapy
  2. Continue heparin and add cangrelor
  3. Stop heparin and start bivalirudin monotherapy
  4. Stop heparin and start bivalirudin + cangrelor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clopidogrel: STEMI

A

Give in Cath lab if not given already in ED as part of early tx

Genetic variability with CYP2C19*2 (avoid omeprazole esomeprazole, can use pantoprazole/HSRA)

Dose: 300 mg LD (for fibrinolysis), 75 mg QD MD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prasugrel: STEMI

A

CI in TIA/STROKE history

LD 60 mg, 10 mg QD MD (< 60 kg: 5 mg)

Only indicated in ACS to be managed with PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ticagrelor: STEMI

A

Indicated for ACS (PCI or non-invasive medical management)

LD 180 mg, 90 mg BID MD

Dyspnea AE (caution asthma/copd)

Can’t use in ICH patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ICU/Ward: Later TX for 2ndary Prevention for STEMI

A

-ACEI (within 24 hr for AMI/STEMI/<40LVEF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NSTEMI: Early Pharm in ED

A

*Don’t use fibrinolytics

-Heparin IV: 60 u/kg (5k max), 12 u/kg (1k max)
+/- Metoprolol IV
-MONA

*Clopidogrel, ticagrelor, prasugrel, or cangrelor for PCI
*Clopidogrel or ticagrelor for med man only

17
Q

Secondary Prevention after MI: ICU/Ward

A

-Aspirin 81 mg
-Rivaroxaban (wait until DAPT complete)
-Clopidogrel, prasu, tica (tica/pras > clop if no CI for stroke/tia)
-BB (MC) for 1 year (up to 3) and indef for EF < 40
-ACEI (avoid renal failure/highK)
-Statins (high intensity)
-Spironolactone or Eplerenone (25 mg both)
-SGLT2is or GLP1RAs

= ABC RASSS